Recurrence 11 years after complete response to gemcitabine, 5-fluorouracil, and cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer: A case report

Tomoyuki Uchihara; Yo Ichi Yamashita; Wang Hualin; Kazuki Takeishi; Shinji Itoh; Norihumi Harimoto; Tomoharu Yoshizumi; Shinichi Aishima; Ken Shirabe; Hideo Baba; Yoshihiko Maehara

Recurrence 11 years after complete response to gemcitabine, 5-fluorouracil, and cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer: A case report

Tomoyuki Uchihara, Yo Ichi Yamashita, Wang Hualin, Kazuki Takeishi, Shinji Itoh, Norihumi Harimoto, Tomoharu Yoshizumi, Shinichi Aishima, Ken Shirabe, Hideo Baba, Yoshihiko Maehara

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

A 63-year-old man diagnosed with locally advanced pancreatic ductal adenocarcinoma (PDAC; stage IIa) was treated with chemotherapy (gemcitabine, 5-fluorouracil and cisplatin) followed by radiotherapy. He had complete response by imaging and relapse-free survival for 11 years. However, he subsequently presented with local tumor recurrence and underwent pancreaticoduodenectomy followed by chemotherapy; a partial response was achieved. As in liver metastasis of colonic cancer, complete response by imaging in PDAC may not mean pathological complete response. We would propose the importance of adjuvant surgery for a patient with PDAC with complete response by imaging after chemoradiotherapy.

Original language	English
Pages (from-to)	2867-2872
Number of pages	6
Journal	Anticancer research
Volume	35
Issue number	5
Publication status	Published - May 1 2015

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Uchihara, T., Yamashita, Y. I., Hualin, W., Takeishi, K., Itoh, S., Harimoto, N., Yoshizumi, T., Aishima, S., Shirabe, K., Baba, H., & Maehara, Y. (2015). Recurrence 11 years after complete response to gemcitabine, 5-fluorouracil, and cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer: A case report. Anticancer research, 35(5), 2867-2872.

Recurrence 11 years after complete response to gemcitabine, 5-fluorouracil, and cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer: A case report. / Uchihara, Tomoyuki; Yamashita, Yo Ichi; Hualin, Wang et al.
In: Anticancer research, Vol. 35, No. 5, 01.05.2015, p. 2867-2872.

Research output: Contribution to journal › Article › peer-review

Uchihara, T, Yamashita, YI, Hualin, W, Takeishi, K, Itoh, S, Harimoto, N, Yoshizumi, T, Aishima, S, Shirabe, K, Baba, H & Maehara, Y 2015, 'Recurrence 11 years after complete response to gemcitabine, 5-fluorouracil, and cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer: A case report', Anticancer research, vol. 35, no. 5, pp. 2867-2872.

@article{ebbca59d6c9b47d3bb52939066dda8f9,

title = "Recurrence 11 years after complete response to gemcitabine, 5-fluorouracil, and cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer: A case report",

abstract = "A 63-year-old man diagnosed with locally advanced pancreatic ductal adenocarcinoma (PDAC; stage IIa) was treated with chemotherapy (gemcitabine, 5-fluorouracil and cisplatin) followed by radiotherapy. He had complete response by imaging and relapse-free survival for 11 years. However, he subsequently presented with local tumor recurrence and underwent pancreaticoduodenectomy followed by chemotherapy; a partial response was achieved. As in liver metastasis of colonic cancer, complete response by imaging in PDAC may not mean pathological complete response. We would propose the importance of adjuvant surgery for a patient with PDAC with complete response by imaging after chemoradiotherapy.",

author = "Tomoyuki Uchihara and Yamashita, {Yo Ichi} and Wang Hualin and Kazuki Takeishi and Shinji Itoh and Norihumi Harimoto and Tomoharu Yoshizumi and Shinichi Aishima and Ken Shirabe and Hideo Baba and Yoshihiko Maehara",

year = "2015",

month = may,

day = "1",

language = "English",

volume = "35",

pages = "2867--2872",

journal = "Anticancer research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "5",

}

TY - JOUR

T1 - Recurrence 11 years after complete response to gemcitabine, 5-fluorouracil, and cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer

T2 - A case report

AU - Uchihara, Tomoyuki

AU - Yamashita, Yo Ichi

AU - Hualin, Wang

AU - Takeishi, Kazuki

AU - Itoh, Shinji

AU - Harimoto, Norihumi

AU - Yoshizumi, Tomoharu

AU - Aishima, Shinichi

AU - Shirabe, Ken

AU - Baba, Hideo

AU - Maehara, Yoshihiko

PY - 2015/5/1

Y1 - 2015/5/1

N2 - A 63-year-old man diagnosed with locally advanced pancreatic ductal adenocarcinoma (PDAC; stage IIa) was treated with chemotherapy (gemcitabine, 5-fluorouracil and cisplatin) followed by radiotherapy. He had complete response by imaging and relapse-free survival for 11 years. However, he subsequently presented with local tumor recurrence and underwent pancreaticoduodenectomy followed by chemotherapy; a partial response was achieved. As in liver metastasis of colonic cancer, complete response by imaging in PDAC may not mean pathological complete response. We would propose the importance of adjuvant surgery for a patient with PDAC with complete response by imaging after chemoradiotherapy.

AB - A 63-year-old man diagnosed with locally advanced pancreatic ductal adenocarcinoma (PDAC; stage IIa) was treated with chemotherapy (gemcitabine, 5-fluorouracil and cisplatin) followed by radiotherapy. He had complete response by imaging and relapse-free survival for 11 years. However, he subsequently presented with local tumor recurrence and underwent pancreaticoduodenectomy followed by chemotherapy; a partial response was achieved. As in liver metastasis of colonic cancer, complete response by imaging in PDAC may not mean pathological complete response. We would propose the importance of adjuvant surgery for a patient with PDAC with complete response by imaging after chemoradiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84929689273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929689273&partnerID=8YFLogxK

M3 - Article

C2 - 25964569

AN - SCOPUS:84929689273

SN - 0250-7005

VL - 35

SP - 2867

EP - 2872

JO - Anticancer research

JF - Anticancer research

IS - 5

ER -

Recurrence 11 years after complete response to gemcitabine, 5-fluorouracil, and cisplatin chemotherapy followed by radiotherapy in a patient with advanced pancreatic cancer: A case report

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Other files and links

Fingerprint

Cite this